Discover
Visualize rapid, validated insights through real-world data.
Shaping the Future of IBD Drug Development with Real-World Data
Michelle Skornicki, MPH, Natalie Schibell, MPH, and Rohan Shah Inflammatory bowel disease ...
Elevating Cohort Analysis with Population Exploration in Substantiate
Natalie Schibell, MPH and Pippa Hodgkins As healthcare systems navigate increasingly ...
Real-World Evidence in Medical Device Approvals: Strengthening the Path to Regulatory Success
Expanding the Role of Real-World Evidence in Medical Device Regulation Regulatory ...
Enterprise RWE Adoption: Aetion’s Maturity Model for Integration and Leadership
Ashley Jaksa, MPH and Natalie Schibell, MPH Real-World Evidence (RWE) has evolved from ...
Aetion Recognized as a Leader in CB Insights’ Synthetic Patient Data Market Analysis
Aetion has been named a Leader in CB Insights’ Synthetic Patient Data Market Analysis, ...
How Aetion is using generative AI and Amazon Bedrock to translate scientific intent to results
Creating clinically meaningful variables from real-world data is a crucial yet ...
One Year of Aetion® Discover: Driving Innovation in Real-World Evidence Generation
Real-world data (RWD) presents significant complexities that require solutions that blend ...
Aetion® Substantiate Spotlight: Turning Dosing Complexity Into Actions
Michelle Skornicki, MPH; Natalie Schibell, MPH; Pippa Hodgkins; Renee Sajedian Evaluating ...
How Aetion is using generative AI and Amazon Bedrock to unlock hidden insights about patient populations
Advances in artificial intelligence are transforming how researchers analyze and ...
2024 in Review: Aetion’s Impact on Real-World Evidence Generation
In 2024, Aetion continued to redefine real-world evidence (RWE) generation by combining ...
Advancing Evidence: Insights from the 43rd Annual J.P. Morgan Healthcare Conference
The 43rd Annual J.P. Morgan Healthcare Conference provided a platform for thoughtful ...
Linking clinical trial participants to their U.S. real-world data through tokenization: A practical guide
While electronic health record data integration is common in clinical trials, the ...
Custom Analyses: Elevating Aetion® Substantiate’s Capabilities for Tailored Research
Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference
The 43rd Annual J.P. Morgan Healthcare Conference, held from January 13-16, 2025, in San ...
Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence
The increasing availability of rich healthcare datasets, advanced data extraction ...
Aetion Generate 3.6: Privacy Meets Scientific Rigor in Real-World Evidence
At Aetion®, we ensure privacy concerns and compliance hurdles never stand in the way of ...
Feature Spotlight: Transforming RWD Management with Measures Assistant (Beta)
Real-world data (RWD) is the lifeblood of modern healthcare research, driving ...
FDA Expands Dupixent Approval for Adolescents with Chronic Rhinosinusitis with Nasal Polyps, Leveraging RWE Powered by Aetion® Substantiate
Blog authored by:
Driving Innovation in HTA Decision-Making: Aetion participates in RWE4Decisions' 2024 Stakeholder Actions
On November 14th, RWE4Decisions hosted its annual Symposium, this year focusing on how to ...
Tokenization and Real-World Data: Effective Strategies and Best Practices | December 11, 2024
Join us for an interactive session with industry experts, where we’ll address some of the ...
Own the Future of Healthcare: Aetion’s AI/ML Tools Turn Data Into Impact
Healthcare stands at a crossroads. The pressure to deliver better care at lower costs is ...
Frameworks and Tools for Generating Decision-Grade RWE | Jan 12, 2023
Watch the webinar Frameworks and Tools for Generating Decision-Grade RWE to explore ...
Applying AI to RWE and Drug Development
With applications abound, AI is poised to change how RWD/RWE teams operate and how ...
What’s Next for Healthcare in 2025: Emerging Threats, GLP-1 Inhibitors, AI, and the Power of RWE
As 2024 comes to a close and 2025 gets going, major changes in healthcare and drug ...